BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17356233)

  • 1. In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats.
    Djoubissie PO; Snirc V; Sotnikova R; Zurova J; Kyselova Z; Skalska S; Gajdosik A; Javorkova V; Vlkovicova J; Vrbjar N; Stefek M
    Gen Physiol Biophys; 2006 Dec; 25(4):415-25. PubMed ID: 17356233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
    Stefek M; Tsantili-Kakoulidou A; Milackova I; Juskova M; Snirc V; Triantos N
    Bioorg Med Chem; 2011 Dec; 19(23):7181-5. PubMed ID: 22037047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
    Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
    Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of [5-(4-pyrrol-1-yl-benzoyl)-1 H-pyrrol-2-yl)]-acetic acid and in vitro study of its inhibitory activity on aldose reductase enzyme and on protein glycation.
    Anagnostou C; Nicolaou I; Demopoulos VJ
    Pharmazie; 2002 Jul; 57(7):435-7. PubMed ID: 12168519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
    J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-(Benzyloxy)-1H-indol-1-yl]acetic acid, an aldose reductase inhibitor and PPARγ ligand.
    Soltesova Prnova M; Majekova M; Milackova I; Díez-Dacal B; Pérez-Sala D; Ceyhan MS; Banerjee S; Stefek M
    Acta Biochim Pol; 2015; 62(3):523-8. PubMed ID: 26345091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Ishii A; Kotani T; Nagaki Y; Shibayama Y; Toyomaki Y; Okukado N; Ienaga K; Okamoto K
    J Med Chem; 1996 Apr; 39(9):1924-7. PubMed ID: 8627616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
    Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
    J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
    Van Zandt MC; Jones ML; Gunn DE; Geraci LS; Jones JH; Sawicki DR; Sredy J; Jacot JL; Dicioccio AT; Petrova T; Mitschler A; Podjarny AD
    J Med Chem; 2005 May; 48(9):3141-52. PubMed ID: 15857120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications.
    Karasova MJ; Prnova MS; Stefek M
    Pharmazie; 2014 Oct; 69(10):747-51. PubMed ID: 25985564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase in early streptozotocin-induced diabetic rat lens.
    Garadi R; Lou MF
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway.
    Juskova M; Snirc V; Gajdosikova A; Gajdosik A; Krizanova L; Stefek M
    Gen Physiol Biophys; 2009 Dec; 28(4):325-30. PubMed ID: 20097954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides.
    Nicolaou I; Demopoulos VJ
    J Med Chem; 2003 Jan; 46(3):417-26. PubMed ID: 12540241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat lens aldehyde reductase.
    Sato S; Kador PF
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1618-22. PubMed ID: 2501231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications.
    Van Zandt MC; Sibley EO; McCann EE; Combs KJ; Flam B; Sawicki DR; Sabetta A; Carrington A; Sredy J; Howard E; Mitschler A; Podjarny AD
    Bioorg Med Chem; 2004 Nov; 12(21):5661-75. PubMed ID: 15465344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.